Hab Pharmaceuticals And Research Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.39 Cr
as on 16-11-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.08 Cr
as on 16-11-2024
- Satisfied Charges ₹ 57.45 Cr
as on 16-11-2024
- Revenue 30.27%
(FY 2023)
- Profit 99.03%
(FY 2023)
- Ebitda 95.18%
(FY 2023)
- Net Worth 60.56%
(FY 2023)
- Total Assets 32.03%
(FY 2023)
About Hab Pharmaceuticals And Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 3.39 Cr.
The company currently has active open charges totaling ₹29.08 Cr. The company has closed loans amounting to ₹57.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Agarwal, Krishnakumar Agarwal, Sanjiv Garg, and Four other members serve as directors at the Company.
- CIN/LLPIN
U99999MH1997PLC105340
- Company No.
105340
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jan 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hab Pharmaceuticals And Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnakumar Agarwal  | Managing Director | 22-Jan-1997 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinita Agarwal | Director | 04-Apr-2000 | Current |
| Sanjiv Garg | Whole-Time Director | 22-Jan-1997 | Current |
| Saurabh Agarwal | Whole-Time Director | 27-Oct-2007 | Current |
| Renu Garg | Director | 01-Oct-2009 | Current |
| Sureshchandra Agrawal | Director | 04-Oct-2004 | Current |
| Madanan Chulliparambil | Director | 21-Aug-2021 | Current |
Financial Performance of Hab Pharmaceuticals And Research.
Hab Pharmaceuticals And Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.27% increase. The company also saw a substantial improvement in profitability, with a 99.03% increase in profit. The company's net worth Soared by an impressive increase of 60.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hab Pharmaceuticals And Research?
In 2023, Hab Pharmaceuticals And Research had a promoter holding of 96.97% and a public holding of 3.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Signature Pharmaceuticals LimitedActive 29 years 10 monthsKrishnakumar Agarwal, Sanjiv Garg and 1 more are mutual person
Asim Software Solutions Private LimitedActive 36 years 8 monthsKrishnakumar Agarwal, Sanjiv Garg and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Sep 2023 | ₹29.00 Cr | Open |
Bank Of Baroda Creation Date: 02 May 2012 | ₹0.82 M | Open |
Standard Chartered Bank Creation Date: 02 Feb 2023 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Hab Pharmaceuticals And Research?
Hab Pharmaceuticals And Research has a workforce of 157 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hab Pharmaceuticals And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hab Pharmaceuticals And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
